COMP <GO>
EMR vs AAPL // ALTMAN Z-SCORE & DEBT/EQUITY
Emerson Electric Company (NYSE) VS. Apple Inc. (NASDAQ) • 15-METRIC TALLY: EMR 5
— AAPL 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: AAPL
LAST: $164.94 (-3.40%) • MKT CAP: $95.24B
balance-sheet
4.80
LAST: $344.63 (-1.23%) • MKT CAP: $5.03T
balance-sheet
13.54
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMR VS. AAPL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMR | AAPL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.80% | 48.65% | +4.15 | EMR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | 81.38% | -71.68 | AAPL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 30.9x | 30.1x | +0.79 | AAPL | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | 2.72% | +0.08 | EMR | /fcf-yield <GO> |
| Operating Margin | 15.50% | 33.17% | -17.67 | AAPL | /operating-margins <GO> |
| Net Profit Margin | 12.70% | 27.62% | -14.92 | AAPL | /net-margins <GO> |
| Revenue Growth (YoY) | 3.00% | 14.24% | -11.24 | AAPL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.25% | 0.31% | +0.94 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.80 | 13.54 | -8.74 | AAPL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | AAPL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.10% | 5.76% | +2.34 | AAPL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.5 | 55.4 | +1.16 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 1.14 | +0.20 | EMR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.6x | 35.3x | +3.26 | AAPL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.24B | $5.03T | -$4.93T | AAPL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMR REV | AAPL REV | EMR GROSS % | AAPL GROSS % | EMR FCF | AAPL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.02B | $416.16B | 52.8% | 46.9% | $2.67B | $98.77B |
| FY 2024 | $17.49B | $391.04B | 50.8% | 46.2% | $2.91B | $108.81B |
| FY 2023 | $15.16B | $383.29B | 44.0% | 44.1% | -$45.4M | $99.58B |
| FY 2022 | — | $394.33B | — | 43.3% | — | $111.44B |
| FY 2021 | — | $365.82B | — | 41.8% | — | $92.95B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMR // BETA 1.34
AAPL // BETA 1.14